Gapping down
In reaction to earnings/guidance:
In reaction to earnings/guidance:
- VUZI -18.5%, CV -10.8%, DLO -8.1%, POET -7.4%, SPRY -7.4%, RUM -6.5%, ELVA -6.2%, KULR -5.5%, UAMY -5.5%, INFQ -4.8%, XNDU -4.7% (also has entered into discussions for up to $285 mln in funding from govts of Canada and Ontario), NU -3.6%, SPCE -3.5% (also mixed securities shelf offering), BTBT -3.3%, HTFL -3%, KLC -2.7%, ALMS -2.6%, AZ -2.4%, AMAT -1.5%
Other news:
- AARD -35.6% (FDA places full clinical hold on NDA for ARD-101)
- IPWR -19.4% (enters $30 mln registered direct offering)
- BW -9% (prices offering of 10.8 mln shares of common stock at $18.50 per share)
- VELO -6.5% (stock offering by selling shareholders)
- AAOI -4.7% (enters equity dist agreement for up to $600 mln of common stock)
- NEOV -4.3% (names new CFO)
- OWLS -3.9% (stock offering by selling shareholders)
- LAR -3.8% (receives RIGI approval for Cauchari-Olaroz Stage 2 expansion)
- PESI -3.3% (commences stock offering)
- AMPX -2.5% (prices warrant exchange transaction)
- BLDP -1.9% (announces Weichai board nominees resign following share sale)